Skip to main content
Top
Published in: BMC Ophthalmology 1/2019

Open Access 01-12-2019 | Care | Research article

Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine

Authors: Mohammad T. Akkawi, Mohammad M. Shehadeh, Amjaad N. Abu Shams, Doaa M. Al-Hardan, Lara J. Omar, Omar H. Almahmoud, Jamal A. S. Qaddumi

Published in: BMC Ophthalmology | Issue 1/2019

Login to get access

Abstract

Background

Severe Retinopathy of Prematurity (ROP) is a serious vasoproliferative disorder that can affect extremely premature infants. It continues to be one of the most important preventable causes of blindness in children. Our study is aimed at finding the incidence of ROP and its association with some risk factors in Palestine.

Methods

From the 1st of January 2016 to 31st December 2016, a total number of 115 infants who met the criteria for ROP screening in three neonatal intensive care units were included in the study. The medical records of infants were reviewed retrospectively and multiple factors that may be associated with the development of ROP were collected manually.

Results

The incidence of ROP and severe type 1 ROP that require treatment was 23.5 and 11.3% respectively. After conducting univariate analysis of risk factors, statistically significant risk factors affecting the development of ROP in our study were: low gestational age, low birth weight, type of multiple gestation, the presence of affected sibling, low level of Hemoglobin at birth, respiratory distress syndrome, low Hemoglobin level, blood transfusion and days on oxygen supplements with either mechanical, non-mechanical methods or both combined. High bilirubin levels were found as a protective factor against the development of ROP. However, when a multivariate analysis was performed, only low gestational age, total days on oxygen supplement and high bilirubin levels were significant regarding the development of ROP.

Conclusion

The incidence of ROP is considered a relatively low percentage compared to neighboring countries that have higher levels of human development index. Statistically significant risk factors need to be considered when clinicians deal with premature infants.
Literature
1.
go back to reference Omolase CO, Aina AS, Omolase BO, Omolade EO. Causes of blindness and visual impairment at the school for the blind Owo, Nigeria. Annals of Ibadan postgraduate medicine. 2008;6(1):49.PubMedPubMedCentral Omolase CO, Aina AS, Omolase BO, Omolade EO. Causes of blindness and visual impairment at the school for the blind Owo, Nigeria. Annals of Ibadan postgraduate medicine. 2008;6(1):49.PubMedPubMedCentral
2.
go back to reference Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol. 2006;26 Suppl 1:S46–S50; discussion S63–44.CrossRef Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol. 2006;26 Suppl 1:S46–S50; discussion S63–44.CrossRef
3.
go back to reference Terry T. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens I. preliminary report. Am J Ophthalmol. 1942;25:203–4.CrossRef Terry T. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens I. preliminary report. Am J Ophthalmol. 1942;25:203–4.CrossRef
4.
go back to reference Courtright P, Hutchinson AK, Lewallen S. Visual impairment in children in middle- and lower-income countries. Arch Dis Child. 2011;96(12):1129–34.CrossRef Courtright P, Hutchinson AK, Lewallen S. Visual impairment in children in middle- and lower-income countries. Arch Dis Child. 2011;96(12):1129–34.CrossRef
5.
go back to reference Blencowe H, Lawn J, Vazquez T, Fielder A, and Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. 2013;74(1):35–49. Blencowe H, Lawn J, Vazquez T, Fielder A, and Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. 2013;74(1):35–49.
6.
go back to reference Sohaila A, Tikmani SS, Khan IA, et al. Frequency of retinopathy of prematurity in premature neonates with a birth weight below 1500 grams and a gestational age less than 32 weeks: a study from a tertiary Care Hospital in a Lower-Middle income country …. PLoS One. 2014;9(7).CrossRef Sohaila A, Tikmani SS, Khan IA, et al. Frequency of retinopathy of prematurity in premature neonates with a birth weight below 1500 grams and a gestational age less than 32 weeks: a study from a tertiary Care Hospital in a Lower-Middle income country …. PLoS One. 2014;9(7).CrossRef
7.
go back to reference Ebtisam K, Al Alawi E, Al Omran MS, Al Bahrana EH. Incidence of retinopathy of prematurity in Bahrain, 2002–2011. Middle East Afr J Ophthalmol. 2015;22(3):335–9.CrossRef Ebtisam K, Al Alawi E, Al Omran MS, Al Bahrana EH. Incidence of retinopathy of prematurity in Bahrain, 2002–2011. Middle East Afr J Ophthalmol. 2015;22(3):335–9.CrossRef
8.
go back to reference Yau GSK, JWYL VTYT, Liu CCL, Yip S, Cheng E, Chu BCY, Yuen CYF. Incidence and risk factors of retinopathy of prematurity from 2 neonatal intensive care units in a Hong Kong Chinese population. Asia-Pacific journal of Ophthalmology. 2016;5:3.CrossRef Yau GSK, JWYL VTYT, Liu CCL, Yip S, Cheng E, Chu BCY, Yuen CYF. Incidence and risk factors of retinopathy of prematurity from 2 neonatal intensive care units in a Hong Kong Chinese population. Asia-Pacific journal of Ophthalmology. 2016;5:3.CrossRef
9.
go back to reference Adedayo AO, Rosemary UO, Chidi NG, Augusta EU. Retinopathy of prematurity in Port Harcourt, Nigeria. ISRN Ophthalmol. 2014. Adedayo AO, Rosemary UO, Chidi NG, Augusta EU. Retinopathy of prematurity in Port Harcourt, Nigeria. ISRN Ophthalmol. 2014.
10.
go back to reference Freitas AM, Mörschbächer R, Thorell MR, Rhoden EL. Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study. Int J Retina Vitreous. 2018;4:20.CrossRef Freitas AM, Mörschbächer R, Thorell MR, Rhoden EL. Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study. Int J Retina Vitreous. 2018;4:20.CrossRef
11.
go back to reference Maroufizadeh S, Almasi-Hashiani A, Omani Samani R, Sepidarkish M. Prevalence of retinopathy of prematurity in Iran: a systematic review and meta-analysis. Int J Ophthalmol. 2017;10(8):1273–9.PubMedPubMedCentral Maroufizadeh S, Almasi-Hashiani A, Omani Samani R, Sepidarkish M. Prevalence of retinopathy of prematurity in Iran: a systematic review and meta-analysis. Int J Ophthalmol. 2017;10(8):1273–9.PubMedPubMedCentral
12.
go back to reference Haugen OH, Markestad T. Incidence of retinopathy of prematurity (ROP) in the western part of Norway. A population-based retrospective study. Acta Ophthalmol Scand. 1997;75(3):305–7.CrossRef Haugen OH, Markestad T. Incidence of retinopathy of prematurity (ROP) in the western part of Norway. A population-based retrospective study. Acta Ophthalmol Scand. 1997;75(3):305–7.CrossRef
13.
go back to reference Zin A, Florencio T, Fortes Filho JB, et al. Brazilian guidelines proposal for screening and treatment of retinopathy of prematurity (ROP). Arq Bras Oftalmol. 2007;70(5):875–83.CrossRef Zin A, Florencio T, Fortes Filho JB, et al. Brazilian guidelines proposal for screening and treatment of retinopathy of prematurity (ROP). Arq Bras Oftalmol. 2007;70(5):875–83.CrossRef
14.
go back to reference The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9.CrossRef The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9.CrossRef
15.
go back to reference Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518–25.CrossRef Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518–25.CrossRef
16.
go back to reference Hardy RJ, Good WV, Dobson V, et al. The early treatment for retinopathy of prematurity clinical trial: presentation by subgroups versus analysis within subgroups. Br J Ophthalmol. 2006;90(11):1341–2.CrossRef Hardy RJ, Good WV, Dobson V, et al. The early treatment for retinopathy of prematurity clinical trial: presentation by subgroups versus analysis within subgroups. Br J Ophthalmol. 2006;90(11):1341–2.CrossRef
17.
go back to reference Jacob MK, Sawardekar KP, Ayoub HG, Al Busaidic I. Validation of the existing modified screening criteria for detection of all cases of retinopathy of prematurity in preterm babies – 11 year study from a governorate referral hospital in Oman. Saudi Journal of Ophthalmology. 2016;30(1):3–8.CrossRef Jacob MK, Sawardekar KP, Ayoub HG, Al Busaidic I. Validation of the existing modified screening criteria for detection of all cases of retinopathy of prematurity in preterm babies – 11 year study from a governorate referral hospital in Oman. Saudi Journal of Ophthalmology. 2016;30(1):3–8.CrossRef
18.
go back to reference Wani VB, Kumar N, Sabti KH, et al. Results of screening for retinopathy of prematurity in a large nursery in Kuwait: incidence and risk factors. Indian J Pediatr. 2010;58(3):204–8. Wani VB, Kumar N, Sabti KH, et al. Results of screening for retinopathy of prematurity in a large nursery in Kuwait: incidence and risk factors. Indian J Pediatr. 2010;58(3):204–8.
19.
go back to reference Waheeb S, Alshehri K. Incidence of retinopathy of prematurity at two tertiary centers in Jeddah, Saudi Arabia. Saudi Journal of Ophthalmology. 2016;30:109–12.CrossRef Waheeb S, Alshehri K. Incidence of retinopathy of prematurity at two tertiary centers in Jeddah, Saudi Arabia. Saudi Journal of Ophthalmology. 2016;30:109–12.CrossRef
20.
go back to reference Gharaibeh AL, Khassawneh M, Khriesat W, Alkhatib SH, Migdadi Y. Adopting Western retinopathy of prematurity screening programs in eastern countries, are we screening properly? Middle East Afr J Ophthalmol. 2011;18(3):209–13.CrossRef Gharaibeh AL, Khassawneh M, Khriesat W, Alkhatib SH, Migdadi Y. Adopting Western retinopathy of prematurity screening programs in eastern countries, are we screening properly? Middle East Afr J Ophthalmol. 2011;18(3):209–13.CrossRef
21.
22.
go back to reference Omer IM, Hassan HA. The prevalence and risk factors of retinopathy of prematurity among preterm babies admitted to soba neonatal intensive care unit. Sudan J Paediatr. 2014;14(2):17–21.PubMedPubMedCentral Omer IM, Hassan HA. The prevalence and risk factors of retinopathy of prematurity among preterm babies admitted to soba neonatal intensive care unit. Sudan J Paediatr. 2014;14(2):17–21.PubMedPubMedCentral
23.
go back to reference Alizadeh Y, Zarkesh M, Moghadam RS, et al. Incidence and risk factors for retinopathy of prematurity in north of Iran. J Ophthalmic Vis Res. 2015;10(4):424–8.CrossRef Alizadeh Y, Zarkesh M, Moghadam RS, et al. Incidence and risk factors for retinopathy of prematurity in north of Iran. J Ophthalmic Vis Res. 2015;10(4):424–8.CrossRef
24.
go back to reference Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6). Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6).
25.
go back to reference Lermann VL, Fortes Filho JB, Procianoy RS. The prevalence of retinopathy of prematurity in very low birth weight newborn infants. J Pediatr. 2006;82(1):27–32.CrossRef Lermann VL, Fortes Filho JB, Procianoy RS. The prevalence of retinopathy of prematurity in very low birth weight newborn infants. J Pediatr. 2006;82(1):27–32.CrossRef
26.
go back to reference Haines L, Fielder AR, Baker H, Wilkinson AR. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F240–4.CrossRef Haines L, Fielder AR, Baker H, Wilkinson AR. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F240–4.CrossRef
27.
go back to reference Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand neonatal network. Pediatrics. 2005;115(4):990–6.CrossRef Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand neonatal network. Pediatrics. 2005;115(4):990–6.CrossRef
28.
go back to reference Gonçalves E, Násser LS, Martelli DR, et al. Incidence and risk factors for retinopathy of prematurity in a Brazilian reference service. Sao Paulo Med J. 2014;132(2):85–91.CrossRef Gonçalves E, Násser LS, Martelli DR, et al. Incidence and risk factors for retinopathy of prematurity in a Brazilian reference service. Sao Paulo Med J. 2014;132(2):85–91.CrossRef
29.
go back to reference Akter SH, Hossain MM, Shirin M, Khalil I, Anwar K. Blood transfusion: a risk factor in retinopathy of prematurity. Bangladesh Journal of Child Health. 2010;34:2. Akter SH, Hossain MM, Shirin M, Khalil I, Anwar K. Blood transfusion: a risk factor in retinopathy of prematurity. Bangladesh Journal of Child Health. 2010;34:2.
30.
go back to reference Abdel HAA. Hakeem GBM, and Mohamed F. Othman. Retinopathy of Prematurity: A Study of Prevalence and Risk Factors. 2012;19(3):289–04. Abdel HAA. Hakeem GBM, and Mohamed F. Othman. Retinopathy of Prematurity: A Study of Prevalence and Risk Factors. 2012;19(3):289–04.
31.
go back to reference Banerjee J, Asamoah F, JK M, N A. Association. Between blood transfusion and development of retinopathy of prematurity - systematic review of literature and meta-analysis. Arch Dis Child. 2014;99(2):184–5. Banerjee J, Asamoah F, JK M, N A. Association. Between blood transfusion and development of retinopathy of prematurity - systematic review of literature and meta-analysis. Arch Dis Child. 2014;99(2):184–5.
32.
go back to reference Reyes Z, Al-Mulaabed SH, Bataclan F, et al. Retinopathy of prematurity: revisiting incidence and risk factors from Oman compared to other countries. Oman J Ophthalmol. 2014;10(1):26–32. Reyes Z, Al-Mulaabed SH, Bataclan F, et al. Retinopathy of prematurity: revisiting incidence and risk factors from Oman compared to other countries. Oman J Ophthalmol. 2014;10(1):26–32.
33.
go back to reference Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E, Dodik I, Duvnjak S. Risk factors for retinopathy of prematurity in premature born children. Med Arch. 2015;69(6):409–713.CrossRef Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E, Dodik I, Duvnjak S. Risk factors for retinopathy of prematurity in premature born children. Med Arch. 2015;69(6):409–713.CrossRef
34.
go back to reference González Viejo I, Ferrer Novella C, Pueyo Royo V, et al. Is patent ductus arteriosus a risk factor for retinopathy of prematurity? An Pediatr (Barc). 2011;74(1):25–30.CrossRef González Viejo I, Ferrer Novella C, Pueyo Royo V, et al. Is patent ductus arteriosus a risk factor for retinopathy of prematurity? An Pediatr (Barc). 2011;74(1):25–30.CrossRef
35.
go back to reference Fauchère J-C, Meier-Gibbons F, Koerner F, Bossi E. Retinopathy of prematurity and bilirubinno clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant. Eur J Pediatr. 1994;153(5):358–62.CrossRef Fauchère J-C, Meier-Gibbons F, Koerner F, Bossi E. Retinopathy of prematurity and bilirubinno clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant. Eur J Pediatr. 1994;153(5):358–62.CrossRef
36.
go back to reference Gaton DD, Gold J, Axer-Siegel R, Wielunsky E, Naor N, Nissenkorn I. Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol. 1991;75(9):532–4.CrossRef Gaton DD, Gold J, Axer-Siegel R, Wielunsky E, Naor N, Nissenkorn I. Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol. 1991;75(9):532–4.CrossRef
37.
go back to reference Heyman E, Ohlsson A, Girschek P. Retinopathy of prematurity and bilirubin. N Engl J Med. 1989;26(4):256. Heyman E, Ohlsson A, Girschek P. Retinopathy of prematurity and bilirubin. N Engl J Med. 1989;26(4):256.
38.
go back to reference Organization WH. Assessment of availability, accessibility and distribution of neonatal health services at Palestinian hospitals. 2018. Organization WH. Assessment of availability, accessibility and distribution of neonatal health services at Palestinian hospitals. 2018.
Metadata
Title
Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine
Authors
Mohammad T. Akkawi
Mohammad M. Shehadeh
Amjaad N. Abu Shams
Doaa M. Al-Hardan
Lara J. Omar
Omar H. Almahmoud
Jamal A. S. Qaddumi
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Care
Published in
BMC Ophthalmology / Issue 1/2019
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-019-1180-4

Other articles of this Issue 1/2019

BMC Ophthalmology 1/2019 Go to the issue